Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

66 filings reported holding LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.6M shares of 73.4M outstanding shares and own 36.17% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (3.37M shares), JANUS HENDERSON GROUP PLC (3.16M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.6M shares), CITADEL ADVISORS LLC (2.56M shares), D1 Capital Partners L.P. (2.51M shares), Omega Fund Management, LLC (2.36M shares), Novo Holdings A/S (1.45M shares), BRAIDWELL LP (1.38M shares), Vestal Point Capital, LP (840K shares), and Woodline Partners LP (824K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.